“There is no profit in curing the body if, in the process, we destroy the soul.”
Those words, spoken by Samuel H. Golter, one of our early leaders, is the credo that has guided City of Hope’s approach to patient care. We remain committed to treating the whole person by providing not only the best medical care possible, but also by providing that care in an atmosphere of kindness and compassion.
Our nurses and hospital staff are trained in the science of supportive care, but and the
Sheri & Les Biller Patient and Family Resource Center
offers the most integrated array of support services in the country. Patient navigators, for instance, tailor services to match the needs of each patient and family, whether they need help dealing with pain, getting transportation to the medical center or overcoming other barriers.
Also on hand are pain and palliative care physicians, psychiatrists, psychologists, social workers, spiritual care chaplains, and child-life specialists. Partnering with our staff, City of Hope patients and their loved ones find the resources, education and support they need to better manage the challenges related to a serious illness. Other programs at the Biller Resource Center include educational classes designed to better prepare patients and caregivers for treatment, healing arts workshops, and peer support groups.
Synthetic human insulin is now used by millions of people with diabetes worldwide.
Pioneering work in bone marrow transplantation has resulted in potentially life-saving procedures for leukemia, lymphoma and other serious blood disorders.
A method to manufacture immune proteins (known as humanized monoclonal antibodies) has given rise to a new generation of “smart” cancer drugs such as Herceptin for breast cancer, Rituxin for lymphoma and Avastin for colon and other cancers.
Bone marrow transplant procedures are now less painful and more successful.
Islet cell research has resulted in improved treatments for Type 1 diabetes.
A new form of gene therapy achieved the first long-term persistence of anti-HIV genes in patients with AIDS-related lymphoma.
City of Hope is also a leader in
the goal of which is to “translate” new research discoveries from the laboratory into potential treatment therapies as quickly as possible. To do that, we maintain three manufacturing facilities dedicated to the production of potential new therapies. This set-up enables our teams of investigators to create promising treatments without the high cost and delays often encountered by other research centers, and thereby saving years of development time. City of Hope received $80 million in research grants and $225 million in revenues from patented technologies in 2012.
Nationwide, City of Hope is one of 41 Comprehensive Cancer Centers. We are proud of this designation, the highest bestowed by the National Cancer Institute, because it recognizes that we are at the forefront in the work we do to develop and translate scientific knowledge from promising laboratory discoveries into new treatments for cancer patients. As a
Comprehensive Cancer Center,
City of Hope must meet and maintain rigorous world-class standards in multidisciplinary cancer research and develop programs, faculty and facilities that will lead to better approaches to the prevention, diagnosis and treatment of cancer. This designation may also open doors to funding not available to other institutions.
Our scientists collaborate with colleagues around the world, participating in more than 500 projects with more than 400 institutions in 40 states and more than 30 other countries. This means that City of Hope scientists are constantly in the loop of scientific research and breakthroughs, sharing their own knowledge as well as benefiting from the knowledge and experience of colleagues around the country and the globe.
More than 35 years ago, City of Hope was at the vanguard of
bone marrow transplantation (BMT)
when we conducted our first transplantation on a young college student with acute myelogenous leukemia. The pioneering procedure was still considered investigational at the time, but has since become the standard for many life-threatening illnesses. Since then, the City of Hope BMT team has performed more than 11,000 transplantations (known medically as hematopoietic cell transplantation), with a success rate for one-year patient survival that has exceeded expectations for eight consecutive years. Each year thousands of BMT recipients return to our Duarte campus to celebrate not only “the years in their life, but the life in their years.” There is also a
Be the Match Registry
office on our Duarte campus. Be the Match
, which is operated by the National Marrow Donor Program, finds matches for bone marrow and blood stem cell transplants for patients with leukemia, lymphoma and other life-threatening blood diseases.
Patient survival outcomes presented in this
have been compared to national statistics. Our team of doctors, nurses and scientists produce outstanding results and we stand more determined than ever to find new treatments and cures for cancer. The goal of curing cancer isn’t just something we work at. It’s what we live for.
City of Hope's
Irell & Manella Graduate School of Biological Sciences
offers a rigorous program of coursework and laboratory research culminating in a Ph.D. degree. The goal is to develop professionally trained scientists, prepared for a career in academic, medical or industrial research. Our graduates have gone on to fulfilling careers at major universities, research institutions, and pharmaceutical and biotechnology companies.
We are supported by a unique network of more than 20
industry groups and hundreds of fundraising chapters
nationwide, all of which serve as valuable partners in advancing our mission. We have earned the highest rating—four stars—from the nation’s leading charity watchdog, Charity Navigator. The four-star rating places us among the top two percent of charities rated by Charity Navigator.